Jump to content

Follow Us:  Twitter Facebook RSS Feed            




   arrowShare this page:
   

   Get email alerts  Subscribe to FREE Celiac.com email alerts

 
Ads by Google:
Celiac.com Sponsor:                                    


Photo
- - - - -

American Celiac Disease Association


  • Please log in to reply

No replies to this topic

#1 Lisa

 
Lisa

    Advanced Community Member

  • Advanced Members
  • PipPipPipPipPipPip
  • 9,799 posts
 

Posted 04 October 2011 - 02:18 PM

Below please read the recommendations from the American Celiac Disease Association, as the comment period ends today (October 3, 2011) to the FDA, regarding the proposed Gluten Free Labeling legislation.

http://www.celiac.or...ges/cc/acda.pdf

Conclusion
There is no medical intervention for the treatment of celiac disease, no drug, no ongoing
therapy. The treatment, while medically prescribed, is self-administered and in many
instances without medical oversight. Gluten-free foods, in all forms, are the equivalent
of a prescription medication used to manage another lifelong, chronic condition. The
laws differ dramatically with regard to the labeling, and manufacturing between drugs
and foods, and we do not imply the two should be equal.

We do however, implore the FDA to consider the following: it takes an individual, on
average, six years of being ill, of bouncing from doctor to doctor before being properly
diagnosed with celiac disease. Gluten-free foods don’t undergo years of safety testing
before going on the market, like medications. Each and every day, celiac consumers
are placed at risk when trying to determine if the foods intended to maintain their health
are safe. They have only the clarity and accuracy of the labeling on which to rely. It is a
heavy burden, but one that will be eased dramatically with the completion of this
rulemaking.

FDA Deputy Commissioner for Food, Mike Taylor, stated in the teleconference to
stakeholders announcing the reopening of this NPRM, and in the press, that the agency
‘must get this right.’ We cannot agree more and believe that reflecting on the experience
of other countries, the FDA can determine the approach to gluten-free labeling which
best protects and works for the American celiac consumer.

Again, we appreciate the opportunity to comment on these proposed rules and look
forward to working with the FDA to ensure their timely and smooth implementation once
finalized in the third quarter of next year.

Respectfully,
Andrea
Levario,
J.D.
Executive Director
American Celiac Disease Alliance
2504 Duxbury Place
Alexandria, VA 22308
info@americanceliac.org
www.americanceliac.org
703.622.3331

  • 0
Lisa

Gluten Free - August 15, 2004

"Not all who wander are lost" - JRR Tolkien

Celiac.com Sponsor:



0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users

Celiac.com Sponsors: